•
Dec 31, 2021

Myomo Q4 2021 Earnings Report

Myomo reported a 6% increase in fourth-quarter revenue and a gross margin of 77.4%.

Key Takeaways

Myomo, Inc. reported a 6% increase in revenue for the fourth quarter of 2021, reaching $4.0 million. The company's gross margin also improved to 77.4%.

Revenue was $4.0 million, up 6% as the Company successfully managed reimbursement and supply chain challenges during the quarter

Gross margin was 77.4%, up 400 basis points

Backlog increased 18% to 154 units

The reimbursement pipeline as of December 31, 2021 consisted of 808 MyoPro candidates

Total Revenue
$4.03M
Previous year: $3.79M
+6.4%
EPS
-$0.52
Previous year: -$0.37
+40.5%
Gross Margin
77.4%
Backlog Units
154
Gross Profit
$3.12M
Previous year: $2.78M
+12.2%
Cash and Equivalents
$15.5M
Previous year: $12.2M
+26.8%
Free Cash Flow
-$1.85M
Total Assets
$20.1M

Myomo

Myomo

Forward Guidance

Myomo expects to generate continued year-over-year revenue growth for 2022. For the first quarter, the company expects product revenue to be in the range of $2.6 million to $3.0 million, an increase of 11% to 28% over the prior-year quarter.

Positive Outlook

  • Expects to generate continued year-over-year revenue growth for 2022
  • Product revenue for Q1 2022 expected to be between $2.6 million and $3.0 million
  • Q1 2022 revenue expectation represents an increase of 11% to 28% over the prior-year quarter